Poor concentration, hyperactivity, learning abilities and working memory Mental and Behavioural Disorders Mild child/adolescent cognitive disorder
Conditions
Interventions
Active treatment: dietary supplement (Eye q):
Omega-3/omega-6 dietary supplement in capsule form, six times/day providing 558 mg Eicosapentaenoic Acid (EPA), 174 mg Docosahexaenoic Acid (DHA), 60 mg G
Sponsors
Durham County Council (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants attend mainstream school.
Exclusion criteria
Exclusion criteria: Children with: 1. Significant neurological problems 2. Psychiatric conditions 3. Any of the following medical problems: 3.1. Epilepsy 3.2. Cerebral palsy 3.3. Multiple sclerosis 3.4. Myalgic encephalopathy 3.5. Pervasive developmental disorder 3.6. Autism 4. Diagnosed ADHD 5. Consumption of essential fatty-acid supplementation within previous three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Measurement of change in working memory, confirmed by results from Wechsler Intelligence Scale for Children (WISC-III UK) digit span assessment; time frame: 6 months 2. Measurement of change in reading ability, using the Wechsler Objective Reading Dimensions (WORD) assessment; time frame: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Measuring a range of behavioural parameters including cognitive problems, hyperactivity, social problems, ADHD and emotional lability as identified by parents using the Conners' Parent Rating Scales-Long Version (CPRS-L); time frame: 6 months 2. Measuring a range of behavioural parameters including cognitive problems, hyperactivity, social problems, ADHD and emotional lability as identified by teachers using the Conners' Teacher Rating Scales-Long Version (CTRS-L); time frame: 6 months | — |
Countries
United Kingdom
Outcome results
None listed